These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37752238)

  • 1. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice.
    Teper Y; Ye L; Waldron RT; Lugea A; Sun X; Sinnett-Smith J; Hines OJ; Pandol SJ; Rozengurt E; Eibl G
    Sci Rep; 2023 Sep; 13(1):16144. PubMed ID: 37752238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice.
    Hao F; Xu Q; Wang J; Yu S; Chang HH; Sinnett-Smith J; Eibl G; Rozengurt E
    PLoS One; 2019; 14(5):e0216603. PubMed ID: 31100067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model.
    Chang HH; Moro A; Chou CEN; Dawson DW; French S; Schmidt AI; Sinnett-Smith J; Hao F; Hines OJ; Eibl G; Rozengurt E
    Sci Rep; 2018 Apr; 8(1):5899. PubMed ID: 29651002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity.
    Dong TS; Chang HH; Hauer M; Lagishetty V; Katzka W; Rozengurt E; Jacobs JP; Eibl G
    Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G763-G772. PubMed ID: 31545922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical Activity Decreases Inflammation and Delays the Development of Obesity-Associated Pancreatic Ductal Adenocarcinoma.
    Pita-Grisanti V; Velez-Bonet E; Chasser K; Hurst Z; Liette A; Vulic G; Dubay K; Lahooti A; Badi N; Ueltschi O; Gumpper-Fedus K; Hsueh HY; Lahooti I; Chavez-Tomar M; Terhorst S; Knoblaugh SE; Cao L; Huang W; Coss CC; Mace TA; Choueiry F; Hinton A; Culp S; Mitchell JM; Schmandt R; Onstad Grinsfelder M; Basen-Engquist K; Cruz-Monserrate Z
    Cancer Res; 2024 Sep; 84(18):3058-3071. PubMed ID: 38781455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
    Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB
    Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.
    Garcia MN; Grasso D; Lopez-Millan MB; Hamidi T; Loncle C; Tomasini R; Lomberk G; Porteu F; Urrutia R; Iovanna JL
    J Clin Invest; 2014 Nov; 124(11):4709-22. PubMed ID: 25250570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinoma.
    Liu SH; Yu J; Creeden JF; Sutton JM; Markowiak S; Sanchez R; Nemunaitis J; Kalinoski A; Zhang JT; Damoiseaux R; Erhardt P; Brunicardi FC
    Cancer Lett; 2020 Oct; 491():97-107. PubMed ID: 32829010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.
    Xian G; Zhao J; Qin C; Zhang Z; Lin Y; Su Z
    Cancer Lett; 2017 Jan; 385():65-74. PubMed ID: 27840243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.
    Chen K; Qian W; Jiang Z; Cheng L; Li J; Sun L; Zhou C; Gao L; Lei M; Yan B; Cao J; Duan W; Ma Q
    Mol Cancer; 2017 Jul; 16(1):131. PubMed ID: 28738823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mAb Das-1 identifies pancreatic ductal adenocarcinoma and high-grade pancreatic intraepithelial neoplasia with high accuracy.
    Das KK; Brown JW; Fernandez Del-Castillo C; Huynh T; Mills JC; Matsuda Y; Das KM; Mino-Kenudson M
    Hum Pathol; 2021 May; 111():36-44. PubMed ID: 33524436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis.
    Ikezawa K; Hikita H; Shigekawa M; Iwahashi K; Eguchi H; Sakamori R; Tatsumi T; Takehara T
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):185-200.e1. PubMed ID: 28948203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development.
    Rozengurt E; Eibl G
    World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.
    Ta N; Huang X; Zheng K; Zhang Y; Gao Y; Deng L; Zhang B; Jiang H; Zheng J
    Cell Physiol Biochem; 2018; 51(2):711-728. PubMed ID: 30463064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.
    Eibl G; Rozengurt E
    Semin Cancer Biol; 2019 Feb; 54():50-62. PubMed ID: 29079305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression.
    Duan W; Chen K; Jiang Z; Chen X; Sun L; Li J; Lei J; Xu Q; Ma J; Li X; Han L; Wang Z; Wu Z; Wang F; Wu E; Ma Q; Ma Z
    Cancer Lett; 2017 Jan; 385():225-233. PubMed ID: 27773749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention.
    Mohammed A; Janakiram NB; Suen C; Stratton N; Lightfoot S; Singh A; Pathuri G; Ritchie R; Madka V; Rao CV
    Mol Carcinog; 2019 Oct; 58(10):1908-1918. PubMed ID: 31313401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras.
    Asahina K; Balog S; Hwang E; Moon E; Wan E; Skrypek K; Chen Y; Fernandez J; Romo J; Yang Q; Lai K; French SW; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G265-G276. PubMed ID: 31760766
    [No Abstract]   [Full Text] [Related]  

  • 19. Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling.
    Mohammed A; Janakiram NB; Brewer M; Ritchie RL; Marya A; Lightfoot S; Steele VE; Rao CV
    Transl Oncol; 2013 Dec; 6(6):649-59. PubMed ID: 24466367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
    Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.